March is Prostate Cancer Awareness Month, spotlighting the UK’s most common cancer affecting over 4,000 Yorkshire men yearly. The Daisy Appeal is proud to announce a game-changing step forward in Hull and East Riding.
At the charity’s brand-new Molecular Imaging Research Centre (MIRC) at Castle Hill Hospital, Gallium-68 PSMA PET scans are being introduced – detecting and staging prostate cancer with unprecedented precision to guide optimal treatments.
Dr Louis Allott, Head of Radiochemistry at MIRCThe massive difference is accessibility. Currently, local men travel hundreds of miles for these scans. The service will be operational as soon as the anticipated NHS decision to sanction Gallium PSMA is formally announced. We will then produce the radiotracer on-site, no travel, no delays.
Gallium-68 PSMA PET scans offer superior detection of prostate cancer spread. On-site production means Hull and East Riding patients get faster access.
Professor Nick Stafford, Chair of Daisy AppealAs a charity, we fund equipment and research to detect cancer, heart disease and dementia on behalf of the NHS. This generator delivers our founding mission: world-class imaging for our community.
One in eight UK men faces diagnosis in their lifetime (one in four for Black men), with 12,000 deaths yearly. Early detection via advanced imaging dramatically improves outcomes - now accessible locally.
The charity seeks support for research extending this science to more cancers, heart disease, and dementia.
100% of the donations received go to fund vital lifesaving research and provision of medical scanning facilities.
Please note all funds are used in full by the charity to further its objectives.
The Hull and East Yorkshire Medical Research Centre
A Charitable Company Limited by Guarantee in England and Wales. Company No. 4017833
Registered office: Daisy Building, Castle Hill Hospital, Castle Road, Cottingham HU16 5JQ Registered Charity No. 1095652
